Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
DEL PRIS
SecurityDE:ABL / Abbott Laboratories
InstitutionHolocene Advisors, LP
Latest Disclosed Ownership790,916 shares
Latest Disclosed Value $ 81,203,346
Holocene Advisors, LP reports 6.22% decrease in ownership of ABL / Abbott Laboratories

On May 15, 2026 - Holocene Advisors, LP filed a 13F-HR form disclosing ownership of 790,916 shares of Abbott Laboratories (DE:ABL) valued at $70,249,159 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 843,400 shares of Abbott Laboratories. This represents a change in shares of -6.22% during the quarter. The current value of the position is $59,492,702 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ABBOTT LABORATORIES COM 002824100 790,916 -52,484 -6.22 81,203 -23.15 0.1959
2026-02-17 2025-12-31 13F ABBOTT LABS COM 002824100 843,400 843,400 105,670 0.2219
2025-05-15 2025-03-31 13F ABBOTT LABS COM 002824100 0 -396,699 -100.00 0 -100.00
2025-02-14 2024-12-31 13F ABBOTT LABS COM 002824100 396,699 -465,571 -53.99 44,871 -54.36 0.1437
2024-11-14 2024-09-30 13F ABBOTT LABS COM 002824100 862,270 454,635 111.53 98,307 132.09 0.3970
2024-08-14 2024-06-30 13F ABBOTT LABS COM 002824100 407,635 407,635 42,357 0.1768
2022-05-16 2022-03-31 13F ABBOTT LABS COM 002824100 0 -26,337 -100.00 0 -100.00
2022-02-14 2021-12-31 13F ABBOTT LABS COM 002824100 26,337 -37,869 -58.98 3,707 -51.13 0.0193
2021-11-15 2021-09-30 13F ABBOTT LABS COM 002824100 64,206 64,206 7,585 0.0412
2021-08-16 2021-06-30 13F ABBOTT LABS COM 002824100 0 -33,769 -100.00 0 -100.00
2021-05-17 2021-03-31 13F ABBOTT LABS COM 002824100 33,769 33,769 4,047 0.0254
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.